Skip to main content
SpringerLink
Log in

Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: a Preliminary Study with Clinical Relevance

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Hepatocellular carcinoma (HCC) is the most common type of primary malignant tumor in the liver. One of the main features of cancer survival is the generalized loss of growth control exhibited by cancer cells, and Miki is a protein related to the immunoglobulin superfamily that plays an important role in mitosis. We aim to study protein expression levels of Miki in non-tumoral liver and 20 HCCs recruited from a Pathology Department. Clinical information was also obtained. A tissue microarray was performed, and immunohistochemical techniques applied to study protein expression levels of Miki. In normal liver, Miki was weakly expressed, showing nuclear staining in the hepatocytes. Cirrhotic areas and HCCs showed a variety of staining patterns. Most HCC samples showed positive expression, with three different staining patterns being discernible: nuclear, cytoplasmic and mixed. Statistical analysis showed a significant association between grade of differentiation, Ki-67 proliferative index, survival rates and staining patterns. This study has revealed the positive expression of Miki in normal liver, cirrhotic areas and HCCs. Three different staining patterns of Miki expression with clinical relevance were noted in HCCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Stoot JH, Coelen RJ, De Jong MC, Dejong CH (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB 12:509–522

    Article  Google Scholar 

  2. McGlynn KA, London WT (2011) The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15:223–243 vii-x

    Article  Google Scholar 

  3. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

    Article  CAS  Google Scholar 

  4. Ozaki Y, Matsui H, Asou H, Nagamachi A, Aki D, Honda H et al (2012) Poly-ADP ribosylation of Miki by tankyrase-1 promotes centrosome maturation. Mol Cell 47:694–706

    Article  CAS  Google Scholar 

  5. Chang P, Jacobson MK, Mitchison TJ (2004) Poly(ADP-ribose) is required for spindle assembly and structure. Nature 432:645–649

    Article  CAS  Google Scholar 

  6. Asou H, Matsui H, Ozaki Y, Nagamachi A, Nakamura M, Aki D et al (2009) Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome. Biochem Biophys Res Commun 383:245–251

    Article  CAS  Google Scholar 

  7. Nigg EA (2002) Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2:815–825

    Article  CAS  Google Scholar 

  8. Chung Moh M, Hoon Lee L, Shen S (2005) Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma. J Hepatol 42:833–841

    Article  Google Scholar 

  9. Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J et al (2010) Antibody validation. BioTechniques 48:197–209

    Article  CAS  Google Scholar 

  10. Kondo Y (1985) Histologic features of hepatocellular carcinoma and allied disorders. Pathol Annu 20(Pt 2):405–430

    PubMed  Google Scholar 

  11. Sugihara S, Nakashima O, Kojiro M, Majima Y, Tanaka M, Tanikawa K (1992) The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy. Cancer 70:1488–1492

    Article  CAS  Google Scholar 

  12. Hidaka T, Hama S, Shrestha P, Saito T, Kajiwara Y, Yamasaki F et al (2009) The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma. Anticancer Res 29:597–603

    PubMed  Google Scholar 

  13. Matsuda Y, Yoshimura H, Ishiwata T, Sumiyoshi H, Matsushita A, Nakamura Y, et al (2016) Mitotic index and multipolar mitosis in routine histologic sections as prognostic markers of pancreatic cancers: a clinicopathological study. Pancreatology : official journal of the international association of Pancreatology16:127–132

  14. Batistatou A (2004) Mitoses and cancer. Med Hypotheses 63(2):281

    Article  CAS  Google Scholar 

  15. Gisselsson D, Hakanson U, Stoller P, Marti D, Jin Y, Rosengren AH et al (2008) When the genome plays dice: circumvention of the spindle assembly checkpoint and near-random chromosome segregation in multipolar cancer cell mitoses. PLoS One 3:e1871

    Article  Google Scholar 

  16. Chan KS, Koh CG, Li HY (2012) Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis 3:e411

    Article  Google Scholar 

  17. Hallett RM, Huang C, Motazedian A, Auf der Mauer S, Pond GR, Hassell JA et al (2015) Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy. Oncotarget 6:7040–7052

    PubMed  PubMed Central  Google Scholar 

  18. Weaver BA (2014) How Taxol/paclitaxel kills cancer cells. Mol Biol Cell 25:2677–2681

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by Pathology Department at Hospital Universitario de Araba-Txagorritxu.

Author information

Authors and Affiliations

  1. Department of Pathology, Hospital Universitario de Araba-Txagorritxu, Vitoria-Gasteiz, Spain

    Iván Fernández-Vega, Emma Camacho-Urkaray, Laura Lorente-Gea, Francisco Borja Gutiérrez-Corres, Isabel Guerra-Merino & José Javier Aguirre

  2. Department of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain

    Iván Fernández-Vega & Jorge Santos-Juanes

  3. Instituto Universitario Fernández-Vega, Oviedo, Spain

    Iván Fernández-Vega, Beatriz García & Luis M. Quirós

  4. Service of Anatomic Pathology, Hospital Universitario de Araba-Txagorritxu, C/Jose Atxotegui s/n, E-01009, Vitoria-Gasteiz, Alava, Spain

    Iván Fernández-Vega

  5. Department of Functional Biology, University of Oviedo, Oviedo, Spain

    Luis M. Quirós

Authors
  1. Iván Fernández-Vega
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge Santos-Juanes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emma Camacho-Urkaray
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laura Lorente-Gea
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Beatriz García
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francisco Borja Gutiérrez-Corres
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luis M. Quirós
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Isabel Guerra-Merino
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. José Javier Aguirre
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

IFV made the diagnoses of hepatocellular carcinomas, carried out the TMA preparations together with ECU, and coordinated the study. Immunohistochemistry was carried out by FBGC. Data analyses were performed by JSJ, and JJA. LLG, ECU and IFV carried out and interpreted the staining, contributed to data analyses and drafted the manuscript. BG, IGM and LMQ provided technical support and critically reviewed the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Iván Fernández-Vega.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest in the research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fernández-Vega, I., Santos-Juanes, J., Camacho-Urkaray, E. et al. Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: a Preliminary Study with Clinical Relevance. Pathol. Oncol. Res. 26, 167–173 (2020). https://doi.org/10.1007/s12253-018-0387-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-018-0387-7

Keywords

Search

Navigation